Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Ishikawa

Showing results (311-320 of 404) with videos related to

Pageof 41
Sort By:
Cancers|March 13, 2024
Long-Term Outcomes of Ablative Carbon-Ion Radiotherapy for Central Non-Small Cell Lung Cancer: A Single-Center, Retrospective StudyShuri Aoki, Hitoshi Ishikawa, Mio Nakajima, et al.
Cancer Science|June 9, 2021
Long-term clinical outcomes after 12-fractionated carbon-ion radiotherapy for localized prostate cancerHiraku Sato, Goro Kasuya, Hitoshi Ishikawa, et al.
Journal of Neurosurgery. Case Lessons|July 20, 2022
Leber's hereditary optic neuropathy with diffuse white matter changes mimicking gliomatosis cerebri: illustrative caseWakiko Saruta, Ichiyo Shibahara, Hajime Handa, et al.
Oncogene|October 10, 2003
Human wee1 kinase is directly transactivated by and increased in association with c-Fos/AP-1: rheumatoid synovial cells overexpressing these genes go into aberrant mitosisHiroki Kawasaki, Koichiro Komai, Mikiko Nakamura, et al.
International Journal of Radiation Oncology, Biology, Physics|May 31, 2011
Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rateMasahiko Okamoto, Hitoshi Ishikawa, Takeshi Ebara, et al.
Cancer|June 29, 2016
Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapyGoro Kasuya, Hitoshi Ishikawa, Hiroshi Tsuji, et al.
Cancer Biomarkers : Section a of Disease Markers|March 14, 2013
Overexpression of TEX101, a potential novel cancer marker, in head and neck squamous cell carcinomaHiroshi Yoshitake, Hidenori Yokoi, Hitoshi Ishikawa, et al.
Medical Physics|September 10, 2025
Comparison of supine and upright postures for liver respiratory motion management in radiotherapyYusuke Nomura, Taku Inaniwa, Yoshitake Yamada, et al.
Japanese Journal of Ophthalmology|May 16, 2025
Intravenous immunoglobulin for the acute treatment of refractory optic neuritis in JapanYohei Takahashi, Takeshi Kezuka, Keigo Shikishima, et al.
Contemporary Clinical Trials Communications|February 22, 2021
Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) - A study protocol for an open-label, phase II, multicenter studyYuta Sekino, Hitoshi Ishikawa, Tomokazu Kimura, et al.
Pageof 41

Showing results (311-320 of 404) with videos related to

Sort By:
Pageof 41
Cancers|March 13, 2024
Long-Term Outcomes of Ablative Carbon-Ion Radiotherapy for Central Non-Small Cell Lung Cancer: A Single-Center, Retrospective StudyShuri Aoki, Hitoshi Ishikawa, Mio Nakajima, et al.
Cancer Science|June 9, 2021
Long-term clinical outcomes after 12-fractionated carbon-ion radiotherapy for localized prostate cancerHiraku Sato, Goro Kasuya, Hitoshi Ishikawa, et al.
Journal of Neurosurgery. Case Lessons|July 20, 2022
Leber's hereditary optic neuropathy with diffuse white matter changes mimicking gliomatosis cerebri: illustrative caseWakiko Saruta, Ichiyo Shibahara, Hajime Handa, et al.
Oncogene|October 10, 2003
Human wee1 kinase is directly transactivated by and increased in association with c-Fos/AP-1: rheumatoid synovial cells overexpressing these genes go into aberrant mitosisHiroki Kawasaki, Koichiro Komai, Mikiko Nakamura, et al.
International Journal of Radiation Oncology, Biology, Physics|May 31, 2011
Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rateMasahiko Okamoto, Hitoshi Ishikawa, Takeshi Ebara, et al.
Cancer|June 29, 2016
Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapyGoro Kasuya, Hitoshi Ishikawa, Hiroshi Tsuji, et al.
Cancer Biomarkers : Section a of Disease Markers|March 14, 2013
Overexpression of TEX101, a potential novel cancer marker, in head and neck squamous cell carcinomaHiroshi Yoshitake, Hidenori Yokoi, Hitoshi Ishikawa, et al.
Medical Physics|September 10, 2025
Comparison of supine and upright postures for liver respiratory motion management in radiotherapyYusuke Nomura, Taku Inaniwa, Yoshitake Yamada, et al.
Japanese Journal of Ophthalmology|May 16, 2025
Intravenous immunoglobulin for the acute treatment of refractory optic neuritis in JapanYohei Takahashi, Takeshi Kezuka, Keigo Shikishima, et al.
Contemporary Clinical Trials Communications|February 22, 2021
Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) - A study protocol for an open-label, phase II, multicenter studyYuta Sekino, Hitoshi Ishikawa, Tomokazu Kimura, et al.
Pageof 41